Clinical Trials in Detroit

Showing 5341-5360 of 14,997 trials

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

NCT04723537

A 2-part, multicenter, Phase 2/3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of upamostat in adult patients with COVID-19 disease who do not require inpatient care.

Covid19

RedHill Biopharma Limited61 participantsStarted Feb 2021

Cutler Bay, Florida, United States • Hialeah, Florida, United States • Miami, Florida, United States +14 more locations

TERMINATEDPhase 2< 1 mile

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

NCT04404361

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.

COVID19COVID-19COVID

CTI BioPharma200 participantsStarted May 2020

Orange, California, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +18 more locations

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Find Trials by Condition in Detroit

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

The Preliminary Effects of Empower@Home

The Effect of Real Time Analytics on Adverse Events Among Hospitalized Patients

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Prospective Evaluation of the LithoVue Elite Ureteroscope

Trial for Treatment Refractory Trigeminal Neuralgia

Perampanel Titration and Cognitive Effects

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Rivet PVS Therapy in Group 2 PH-HFpEF

Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS